CIK 0001787306 · Large accelerated filer
Arcutis Biotherapeutics, Inc.
Sign in to watch- Ticker
- ARQT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 812974255
- Phone
- 805-418-5006
- Business address
- 3027 TOWNSGATE ROAD, SUITE 300, WESTLAKE VILLAGE, CA, 91361
- Former names
- Arcutis, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,318,251
- in 11 filings, $2.1M under 10b5-1 plans
Net −$3,318,251. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-02-27 | Vairavan Latha SVP Chief Financial Officer | Grant or award · Stock Option (right to buy) 10b5-1 | +70,000 | 70,000 | ||
| 2026-02-27 | Burnett Patrick See Remarks | Grant or award 10b5-1 | +30,000 | 127,401 | ||
| 2026-02-27 | Burnett Patrick See Remarks | Grant or award · Stock Option (right to buy) 10b5-1 | +77,000 | 77,000 | ||
| 2026-02-04 | Burnett Patrick See Remarks | Sale 10b5-1 | −9,794 | $25.81 | $253K | 80,651 |
| 2026-02-02 | Matsuda Masaru See Remarks | Sale 10b5-1 | −7,983 | $25.50 | $204K | 142,658 |
| 2026-02-02 | Matsuda Masaru See Remarks | Sale 10b5-1 | −8,562 | $24.97 | $214K | 134,096 |
| 2026-02-02 | Matsuda Masaru See Remarks | Sale 10b5-1 | −19,379 | $25.24 | $489K | 114,717 |
| 2026-02-02 | Matsuda Masaru See Remarks | Sale 10b5-1 | −4,714 | $25.63 | $121K | 110,003 |
| 2026-02-02 | Burnett Patrick See Remarks | Sale 10b5-1 | −3,675 | $25.50 | $94K | 90,445 |
| 2026-02-02 | Watanabe Todd See Remarks | Sale 10b5-1 | −19,833 | $25.50 | $506K | 721,306 |
| 2026-02-02 | Vairavan Latha SVP Chief Financial Officer | Sale 10b5-1 | −1,320 | $25.50 | $34K | 63,607 |
| 2026-02-02 | Welgus Howard G. Director | Sale 10b5-1 | −10,000 | $25.05 | $250K | 59,744 |
| 2026-02-02 | Edwards Larry Todd See Remarks | Sale 10b5-1 | −2,052 | $25.50 | $52K | 148,865 |
| 2026-01-05 | Burnett Patrick See Remarks | Sale 10b5-1 | −2,490 | $28.98 | $72K | 94,120 |
| 2026-01-02 | Welgus Howard G. Director | Sale 10b5-1 | −10,000 | $28.96 | $290K | 69,744 |
| 2025-12-31 | Burnett Patrick See Remarks | Sale 10b5-1 | −541 | $28.81 | $16K | 97,766 |
| 2025-12-31 | Burnett Patrick See Remarks | Sale 10b5-1 | −1,156 | $29.39 | $34K | 96,610 |
| 2025-12-15 | Burnett Patrick See Remarks | Option exercise 10b5-1 | +11,500 | $3.64 | $42K | 109,807 |
| 2025-12-15 | Burnett Patrick See Remarks | Sale 10b5-1 | −11,500 | $28.94 | $333K | 98,307 |
| 2025-12-15 | Burnett Patrick See Remarks | Option exercise · Stock Option (right to buy) 10b5-1 | −11,500 | 143,750 |
Page 7 of 13 · 241 trades